DS-1001 is an oral brain-penetrant mutant IDH1 selective inhibitor.
For research use only. We do not sell to patients.
| Name | DS-1001b |
|---|---|
| Iupac Chemical Name | t-Butylamine (E)-3-(1-(5-(2-fluoropropan-2-yl)-3-(2,4,6-trichlorophenyl)isoxazole-4-carbonyl)-3-methyl-1H-indol-4-yl)acrylate |
| Synonyms | DS-1001B ; DS 1001B ; DS1001B ; DS-1001 ; DS 1001 ; DS1001 ; Safusidenib ; Safusidenib Erbumine ; |
| Molecular Formula | C29H29Cl3FN3O4 |
| Molecular Weight | 608.92 |
| Smile | NC(C)(C)C.O=C(O)/C=C/C1=CC=CC2=C1C(C)=CN2C(C3=C(C(C)(F)C)ON=C3C4=C(Cl)C=C(Cl)C=C4Cl)=O |
| InChiKey | UPPAAWQBZQBNIE-USRGLUTNSA-N |
| InChi | InChI=1S/C25H18Cl3FN2O4.C4H11N/c1-12-11-31(17-6-4-5-13(19(12)17)7-8-18(32)33)24(34)21-22(30-35-23(21)25(2,3)29)20-15(27)9-14(26)10-16(20)28;1-4(2,3)5/h4-11H,1-3H3,(H,32,33);5H2,1-3H3/b8-7+; |
| CAS Number | 1898207-64-1 |
| Related CAS | 1898207-64-1 |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | ≧98.0% |
| Storage | Dry, dark and at 0 - 4℃ for short term (days to weeks) or -20℃ for long term (months to years). |
| Solubility | Soluble in DMSO (DMSO : ≥ 100 mg/mL) |
| Handling | Refer to MSDS |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| HS Code | 2934200090 |
| Targets | IDH1 inhibitor |
|---|---|
| Mechanism | DS-1001 is an oral brain-penetrant mutant IDH1 selective inhibitor. |
| Cell study | |
| Animal study | |
| Clinical study |